Abstract
This research investigated a novel folic acid(FA)-modified zirconium core metal-organic framework(MOF) Uio-66 as a nanocarrier to deliver indocyanine green(ICG) and Sunitinib to cancer cells for combination therapy. Platinum-loaded Uio-66 nanoparticles(Pu) were synthesized via a one-pot method, followed by the modification with FA on their surfaces. This afforded FPu that enabled subsequent loading of ICG and Sunitinib to achieve dual-modal cancer therapy. Drug loading/release test and singlet oxygen detection were also conducted in vitro, and the nanoparticles showed considerable drug loading efficiency for both ICG and Sunitinib, coupled with a high singlet oxygen generation rate. Specifically, drug loading and encapsulation efficiency of Sunitinib were 2.30% and 72.67%, while those for ICG were 2.87% and 90.28%, respectively. Additionally, cytotoxicity test on HepG2 human hepatocellular carcinoma cancer cell line revealed that the fully functional nanoparticles possess excellent biocompatibility and as such could be further investigated as a potential drug delivery system for effectual carcinoma cancer treatment.
Similar content being viewed by others
References
Finn R. S., Zhu A.X., Hepatology, 2021, 73, 150
https://www.iarc.who.int/faq/latest-global-cancer-data-2020-qa/ Accessed on 2021-04-26
Lee H. A., Park S., Seo Y. S., Yoon W. S., Shin I. S., Rim C. H., J. Hepatobiliary Pancreat Sci., Epub Ahead of print, PMID: 33179421
McGlynn K. A., Petrick J. L., El-Serag H. B., Hepatology, 2021, 73, 4
Huang A., Yang X. R., Chung W. Y., Dennison A. R., Zhou J., Signal Transduct Target Ther., 2020, 5, 146
Zhu A. X., Sahani D. V., Duda D. G., di Tomaso E., Ancukiewicz M., Catalano O. A., Sindhwani V., Blaszkowsky L. S., Yoon S. S., Lahdenranta J., Bhargava P., Meyerhardt J., Clark J. W., Kwak E. L., Hezel A. F., Miksad R., Abrams T. A., Enzinger P. C., Fuchs C. S., Ryan D. P., Jain R. K., J. Clin. Oncol., 2009, 27, 3027
Polom K., Murawa D., Rho Y. S., Nowaczyk P., Hünerbein M., Murawa P., Cancer, 2011, 117(21), 4812
Baj J., Sitarz R., Łokaj M., Forma A., Czeczelewski M., Maani A., Garruti G., Molecules, 2020, 25(7), 1724
Zhang X., Li Y., Wei M., Liu C., Yu T., Yang J., Drug Deliv., 2019, 26(1), 129
Wang Y., Xie Y., Li J., Peng Z. H., Sheinin Y., Zhou J., Oupický D., ACS Nano, 2017, 11(2), 2227
Yu Z., Xiao Z., Shuai X., Tian J., J. Mater. Chem. B, 2020, 8(30), 6418
Desmettre T., Devoisselle J. M., Mordon S., SurvOphthalmol, 2000, 45(1), 15
Santos J. H., Quimque M. T. J., Macabeo A. P. G., Corpuz M. J. T., Wang Y. M., Lu T. T., Lin C. H., Villaflores O. B., Pharmaceutics, 2020, 12(5), 437
Jarai B. M., Stillman Z., Attia L., Decker G. E., Bloch E. D., Fromen C. A., ACS Appl Mater Interfaces, 2020, 12(35), 38989
Liu C., Luo L., Zeng L., Xing J., Xia Y., Sun S., Zhang L., Yu Z., Yao J., Yu Z., Akakuru O. U., Saeed M., Wu A., Small, 2018, 14(35), e1801851
Ogiwara N., Kobayashi H., Concepción P., Rey F., Kitagawa H., Angew. Chem. Int. Ed. Engl., 2019, 58(34), 11731
Zhang W., Ji W., Li L., Qin P., Khalil I. E., Gu Z., Wang P., Li H., Fan Y., Ren Z., Shen Y., Zhang W., Fu Y., Huo F., ACS Appl. Mater. Interfaces, 2020, 12(47), 52660
Chen S. S., Hu C., Liu C. H., Chen Y. H., Ahamad T., Alshehri S. M., Huang P. H., Wu K. C., J. Hazard Mater., 2020, 397, 122431
Dong H., Yang G. X., Zhang X., Meng X. B., Sheng J. L., Sun X. J., Feng Y. J., Zhang F. M., Chemistry, 2018, 24(64), 17148
Gao X., Cui R., Ji G., Liu Z., Nanoscale, 2018, 10(13), 6205
Dong H., Yang G. X., Zhang X., Meng X. B., Sheng J. L., Sun X. J., Feng Y. J., Zhang F. M., Chemistry, 2018, 24(64), 17148
Liu M. C., Liu L., Wang X. R., Shuai W. P., Hu Y., Han M., Gao J. Q., Int. J. Nanomedicine, 2016, 11, 1395
Koirala N., Das D., Fayazzadeh E., Sen S., McClain A., Puskas J. E., Drazba J. A., McLennan G., J. Biomed. Mater. Res. A, 2019, 107(11), 2522
Kulkarni T. A., Bade A. N., Sillman B., Shetty B. L. D., Wojtkiewicz M. S., Gautam N., Hilaire J. R., Sravanam S., Szlachetka A., Lamberty B. G., Morsey B. M., Fox H. S., Alnouti Y., McMillan J. M., Mosley R. L., Meza J., Domanico P. L., Yue T. Y., Moore G., Edagwa B. J., Gendelman H. E., Nat. Mater., 2020, 19(8), 910
Unciti-Broceta J. D., Arias J. L., Maceira J., Soriano M., Ortiz-González M., Hernández-Quero J., Muñóz-Torres M., de Koning H. P., Magez S., Garcia-Salcedo J. A., PLoSPathog, 2015, 11(6), e1004942
Cassidy L. D., Young A. R., Pérez-Mancera P. A., Nimmervoll B., Jaulim A., Chen H. C., McIntyre D. J. O., Brais R., Ricketts T., Pacey S., De La Roche M., Gilbertson R. J., Rubinsztein D. C., Narita M., Autophagy, 2018, 14(7), 1256
Singletary M., Lau J. W., Hagerty S., Pustovyy O., Globa L., Vodyanoy V., Sci. Rep., 2020, 10(1), 18435
Rojas S., Colinet I., Cunha D., Hidalgo T., Salles F., Serre C., Guillou N., Horcajada P., ACS Omega., 2018, 3(3), 2994
Tabatabaeian K., Simayee M., Fallah-Shojaie A., Mashayekhi F., Daru., 2019, 27(1), 307
Farboudi A., Mahboobnia K., Chogan F., Karimi M., Askari A., Banihashem S., Davaran S., Int. J. Biol. Macromol., 2020, 150, 178
van Dam G. M., Themelis G., Crane L. M., Harlaar N. J., Pleijhuis R. G., Kelder W., Sarantopoulos A., de Jong J. S., Arts H. J., van der Zee A. G., Bart J., Low P. S., Ntziachristos V., Nat. Med., 2011, 17(10), 1315
Zhou Y., Unno K., Hyjek E., Liu H., Zimmerman T., Karmakar S., Putt K. S., Shen J., Low P. S., Wickrema A., Leuk Lymphoma, 2018, 59(12), 2982
Kamen B. A., Smith A. K., Adv. Drug Deliv. Rev., 2004, 56(8), 1085
Brown Jones M., Neuper C., Clayton A., Mariani A., Konecny G., Thomas M. B., Keeney G., Hartmann L., Podratz K. C., Int. J. Cancer., 2008, 123(7), 1699
Iwakiri S., Sonobe M., Nagai S., Hirata T., Wada H., Miyahara R., Ann. Surg. Oncol., 2008, 15(3), 889
Liu Y., Yang G., Jin S., Xu L., Zhao C. X., Chempluschem, 2020, 85(9), 2143
Itatani Y., Kawada K., Yamamoto T., Sakai Y., Int. J. Mol. Sci., 2018, 19(4), 1232
Yang Y., Li N., Chen T., Zhang C., Liu L., Qi Y., Bu P., Pharm. Biol., 2019, 57(1), 625
Yang Y., Li N., Chen T., Zhang C., Li J., Liu L., Qi Y., Zheng X., Zhang C., Bu P., Arch. Toxicol., 2019, 93(11), 3249
Zhao Q., Zhang T., Xiao X. R., Huang J. F., Wang Y., Gonzalez F. J., Li F., Br. J. Pharmacol., 2019, 176(13), 2162
Acknowledgements
This work was supported by the Ningbo Natural Science Foundation, China(No.202003N4253) and the Southeast University-China Pharmaceutical University Cooperative Research Project, China(No.2242019K3DZ06).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare no conflicts of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Zhang, Z., Liu, C., Akakuru, O. et al. ICG and Sunitinib-loaded NH2-MOFs for Folate-mediated Hepatocellular Carcinoma Dual-modal Therapy. Chem. Res. Chin. Univ. 37, 967–974 (2021). https://doi.org/10.1007/s40242-021-1206-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-021-1206-3